The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Perspectives
This section features opinion pieces, reflections, and expert commentary on timely or overlooked issues in cancer care, research, and the oncology workforce.
What Is Metastatic Cancer? Understanding When and How Cancer Spreads
By Dr. Chandra Lalita Kakarala
What metastatic cancer means, how cancer spreads through lymph nodes and blood, common sites of metastasis, symptoms, diagnosis, and modern treatment options for stage 4 cancer.
What Is Metastatic Cancer? Understanding When and How Cancer Spreads
By Dr. Chandra Lalita Kakarala
What metastatic cancer means, how cancer spreads through lymph nodes and blood, common sites of metastasis, symptoms, diagnosis, and modern treatment options for stage 4 cancer.
What Is Metastatic Cancer? Understanding When and How Cancer Spreads
By Dr. Chandra Lalita Kakarala
What metastatic cancer means, how cancer spreads through lymph nodes and blood, common sites of metastasis, symptoms, diagnosis, and modern treatment options for stage 4 cancer.
Dr. Vidhya Nair on De-escalation and Personalized Treatment in HER2-Positive Breast Cancer
By The Cancer News Team
Dr. Vidhya Nair reviews key advances in HER2-positive breast cancer, highlighting de-escalation in early-stage disease, T-DXd in high-risk and metastatic settings, and evolving personalized treatment strategies.
Dr. Vidhya Nair on De-escalation and Personalized Treatment in HER2-Positive Breast Cancer
By The Cancer News Team
Dr. Vidhya Nair reviews key advances in HER2-positive breast cancer, highlighting de-escalation in early-stage disease, T-DXd in high-risk and metastatic settings, and evolving personalized treatment strategies.
Dr. Vidhya Nair on De-escalation and Personalized Treatment in HER2-Positive Breast Cancer
By The Cancer News Team
Dr. Vidhya Nair reviews key advances in HER2-positive breast cancer, highlighting de-escalation in early-stage disease, T-DXd in high-risk and metastatic settings, and evolving personalized treatment strategies.
Dr. Xiaowen Wang on Optimizing Patient Selection in Advanced ER-Positive Breast Cancer
By The Cancer News Team
Dr. Xiaowen Wang reviews evolving strategies for advanced ER-positive metastatic breast cancer, highlighting NGS timing, ESR1 and PIK3CA mutations, novel SERDs, and targeted combination therapies.
Dr. Xiaowen Wang on Optimizing Patient Selection in Advanced ER-Positive Breast Cancer
By The Cancer News Team
Dr. Xiaowen Wang reviews evolving strategies for advanced ER-positive metastatic breast cancer, highlighting NGS timing, ESR1 and PIK3CA mutations, novel SERDs, and targeted combination therapies.
Dr. Xiaowen Wang on Optimizing Patient Selection in Advanced ER-Positive Breast Cancer
By The Cancer News Team
Dr. Xiaowen Wang reviews evolving strategies for advanced ER-positive metastatic breast cancer, highlighting NGS timing, ESR1 and PIK3CA mutations, novel SERDs, and targeted combination therapies.
Highlights of ASCO Gastrointestinal Cancer Symposium 2026: From Bench to Bedside
By Dr. Meghana Singh
Key clinical trial highlights from ASCO GI 2026, covering practice-changing data in gastric, colorectal, pancreatic, and liver cancers, including HERIZON GEA-01, ILLUSTRO, COMMIT II, and BREAKWATER.
Highlights of ASCO Gastrointestinal Cancer Symposium 2026: From Bench to Bedside
By Dr. Meghana Singh
Key clinical trial highlights from ASCO GI 2026, covering practice-changing data in gastric, colorectal, pancreatic, and liver cancers, including HERIZON GEA-01, ILLUSTRO, COMMIT II, and BREAKWATER.
Highlights of ASCO Gastrointestinal Cancer Symposium 2026: From Bench to Bedside
By Dr. Meghana Singh
Key clinical trial highlights from ASCO GI 2026, covering practice-changing data in gastric, colorectal, pancreatic, and liver cancers, including HERIZON GEA-01, ILLUSTRO, COMMIT II, and BREAKWATER.
Caution about Ivermectin for Cancer Treatment from an Oncologist
By Dr. Binay Shah
An oncologist cautions against the use of ivermectin for cancer treatment, explaining why preliminary lab studies and online misinformation do not replace evidence-based clinical trials.
Caution about Ivermectin for Cancer Treatment from an Oncologist
By Dr. Binay Shah
An oncologist cautions against the use of ivermectin for cancer treatment, explaining why preliminary lab studies and online misinformation do not replace evidence-based clinical trials.
Caution about Ivermectin for Cancer Treatment from an Oncologist
By Dr. Binay Shah
An oncologist cautions against the use of ivermectin for cancer treatment, explaining why preliminary lab studies and online misinformation do not replace evidence-based clinical trials.
2025 Oncology Year in Review: Breakthrough Cancer Treatments and Research
By Aishat Motolani, PhD
A comprehensive 2025 oncology year in review exploring breakthroughs in cancer treatment, AI in oncology, immunotherapy approvals, liquid biopsy debates, mRNA vaccines, and global cancer health equity.
2025 Oncology Year in Review: Breakthrough Cancer Treatments and Research
By Aishat Motolani, PhD
A comprehensive 2025 oncology year in review exploring breakthroughs in cancer treatment, AI in oncology, immunotherapy approvals, liquid biopsy debates, mRNA vaccines, and global cancer health equity.
2025 Oncology Year in Review: Breakthrough Cancer Treatments and Research
By Aishat Motolani, PhD
A comprehensive 2025 oncology year in review exploring breakthroughs in cancer treatment, AI in oncology, immunotherapy approvals, liquid biopsy debates, mRNA vaccines, and global cancer health equity.
San Antonio Breast Cancer Symposium 2025: Oncologist's Review of Key Trial Results and Therapeutic Advances
By Dr. Milana Dolezal
An oncologist’s expert review of pivotal clinical trials and therapeutic advances in early and metastatic breast cancer presented at the San Antonio Breast Cancer Symposium 2025.
San Antonio Breast Cancer Symposium 2025: Oncologist's Review of Key Trial Results and Therapeutic Advances
By Dr. Milana Dolezal
An oncologist’s expert review of pivotal clinical trials and therapeutic advances in early and metastatic breast cancer presented at the San Antonio Breast Cancer Symposium 2025.
San Antonio Breast Cancer Symposium 2025: Oncologist's Review of Key Trial Results and Therapeutic Advances
By Dr. Milana Dolezal
An oncologist’s expert review of pivotal clinical trials and therapeutic advances in early and metastatic breast cancer presented at the San Antonio Breast Cancer Symposium 2025.
Understanding PALB2 Mutations in Pancreatic Cancer
By Jonathan W Lee, MD, MSc
November marks Pancreatic Cancer Awareness Month, a time to shine a light on one of oncology's most challenging diseases.
Understanding PALB2 Mutations in Pancreatic Cancer
By Jonathan W Lee, MD, MSc
November marks Pancreatic Cancer Awareness Month, a time to shine a light on one of oncology's most challenging diseases.
Understanding PALB2 Mutations in Pancreatic Cancer
By Jonathan W Lee, MD, MSc
November marks Pancreatic Cancer Awareness Month, a time to shine a light on one of oncology's most challenging diseases.
Palo Alto VA and Stanford Oncologist Advancing Cancer Care
By The Cancer News Team
Dr. Millie Das, Chief of Oncology at the Palo Alto VA and Stanford oncologist, advances precision oncology through clinical trial access and leadership in targeted therapies.
Palo Alto VA and Stanford Oncologist Advancing Cancer Care
By The Cancer News Team
Dr. Millie Das, Chief of Oncology at the Palo Alto VA and Stanford oncologist, advances precision oncology through clinical trial access and leadership in targeted therapies.
Palo Alto VA and Stanford Oncologist Advancing Cancer Care
By The Cancer News Team
Dr. Millie Das, Chief of Oncology at the Palo Alto VA and Stanford oncologist, advances precision oncology through clinical trial access and leadership in targeted therapies.
World Cancer Research Day 2025: Progress, Challenges, and What’s Next in U.S. Cancer Research
By Aishat Motolani, PhD
Explore the progress, challenges, and future directions of U.S. cancer research on World Cancer Research Day 2025, from immunotherapy and RNA vaccines to AI, prevention, and health equity.
World Cancer Research Day 2025: Progress, Challenges, and What’s Next in U.S. Cancer Research
By Aishat Motolani, PhD
Explore the progress, challenges, and future directions of U.S. cancer research on World Cancer Research Day 2025, from immunotherapy and RNA vaccines to AI, prevention, and health equity.
World Cancer Research Day 2025: Progress, Challenges, and What’s Next in U.S. Cancer Research
By Aishat Motolani, PhD
Explore the progress, challenges, and future directions of U.S. cancer research on World Cancer Research Day 2025, from immunotherapy and RNA vaccines to AI, prevention, and health equity.